BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23041622)

  • 21. Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.
    Sacco T; Boda E; Hoxha E; Pizzo R; Cagnoli C; Brusco A; Tempia F
    BMC Neurosci; 2010 Apr; 11():55. PubMed ID: 20426821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
    Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
    Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.
    Musova Z; Kaiserova M; Kriegova E; Fillerova R; Vasovcak P; Santava A; Mensikova K; Zumrova A; Krepelova A; Sedlacek Z; Kanovsky P
    Cerebellum; 2014 Jun; 13(3):331-7. PubMed ID: 24272953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.
    Kondadi AK; Wang S; Montagner S; Kladt N; Korwitz A; Martinelli P; Herholz D; Baker MJ; Schauss AC; Langer T; Rugarli EI
    EMBO J; 2014 May; 33(9):1011-26. PubMed ID: 24681487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of the mitochondrial protease Afg3l2 results in severely diminished respiratory chain activity and widespread defects in mitochondrial gene expression.
    Pareek G; Pallanck LJ
    PLoS Genet; 2020 Oct; 16(10):e1009118. PubMed ID: 33075064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.
    Puchades C; Ding B; Song A; Wiseman RL; Lander GC; Glynn SE
    Mol Cell; 2019 Sep; 75(5):1073-1085.e6. PubMed ID: 31327635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
    Caporali L; Magri S; Legati A; Del Dotto V; Tagliavini F; Balistreri F; Nasca A; La Morgia C; Carbonelli M; Valentino ML; Lamantea E; Baratta S; Schöls L; Schüle R; Barboni P; Cascavilla ML; Maresca A; Capristo M; Ardissone A; Pareyson D; Cammarata G; Melzi L; Zeviani M; Peverelli L; Lamperti C; Marzoli SB; Fang M; Synofzik M; Ghezzi D; Carelli V; Taroni F
    Ann Neurol; 2020 Jul; 88(1):18-32. PubMed ID: 32219868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control of mitochondrial protein synthesis is required for membrane integrity and cell fitness.
    Richter U; Lahtinen T; Marttinen P; Suomi F; Battersby BJ
    J Cell Biol; 2015 Oct; 211(2):373-89. PubMed ID: 26504172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.
    Gorman GS; Pfeffer G; Griffin H; Blakely EL; Kurzawa-Akanbi M; Gabriel J; Sitarz K; Roberts M; Schoser B; Pyle A; Schaefer AM; McFarland R; Turnbull DM; Horvath R; Chinnery PF; Taylor RW
    JAMA Neurol; 2015 Jan; 72(1):106-11. PubMed ID: 25420100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.
    Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T
    J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mitochondrial protease AFG3L2 is essential for axonal development.
    Maltecca F; Aghaie A; Schroeder DG; Cassina L; Taylor BA; Phillips SJ; Malaguti M; Previtali S; Guénet JL; Quattrini A; Cox GA; Casari G
    J Neurosci; 2008 Mar; 28(11):2827-36. PubMed ID: 18337413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration.
    Martinelli P; La Mattina V; Bernacchia A; Magnoni R; Cerri F; Cox G; Quattrini A; Casari G; Rugarli EI
    Hum Mol Genet; 2009 Jun; 18(11):2001-13. PubMed ID: 19289403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.
    Löbbe AM; Kang JS; Hilker R; Hackstein H; Müller U; Nolte D
    J Mol Neurosci; 2014 Apr; 52(4):493-6. PubMed ID: 24293060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recessive AFG3L2 Mutation Causes Progressive Microcephaly, Early Onset Seizures, Spasticity, and Basal Ganglia Involvement.
    Eskandrani A; AlHashem A; Ali ES; AlShahwan S; Tlili K; Hundallah K; Tabarki B
    Pediatr Neurol; 2017 Jun; 71():24-28. PubMed ID: 28449981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The m-AAA Protease Associated with Neurodegeneration Limits MCU Activity in Mitochondria.
    König T; Tröder SE; Bakka K; Korwitz A; Richter-Dennerlein R; Lampe PA; Patron M; Mühlmeister M; Guerrero-Castillo S; Brandt U; Decker T; Lauria I; Paggio A; Rizzuto R; Rugarli EI; De Stefani D; Langer T
    Mol Cell; 2016 Oct; 64(1):148-162. PubMed ID: 27642048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.
    Seong E; Insolera R; Dulovic M; Kamsteeg EJ; Trinh J; Brüggemann N; Sandford E; Li S; Ozel AB; Li JZ; Jewett T; Kievit AJA; Münchau A; Shakkottai V; Klein C; Collins CA; Lohmann K; van de Warrenburg BP; Burmeister M
    Ann Neurol; 2018 Jun; 83(6):1075-1088. PubMed ID: 29604224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28.
    Smets K; Deconinck T; Baets J; Sieben A; Martin JJ; Smouts I; Wang S; Taroni F; Di Bella D; Van Hecke W; Parizel PM; Jadoul C; De Potter R; Couvreur F; Rugarli E; De Jonghe P
    Neurology; 2014 Jun; 82(23):2092-100. PubMed ID: 24814845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients.
    Colucci F; Neri M; Fortunato F; Ferlini A; Carrozzo R; Torraco A; Lamantea E; Legati A; Tecilla G; Pugliatti M; Sensi M
    Cerebellum; 2023 Dec; 22(6):1313-1319. PubMed ID: 36447112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting Substrate Specificities of the Mitochondrial AFG3L2 Protease.
    Ding B; Martin DW; Rampello AJ; Glynn SE
    Biochemistry; 2018 Jul; 57(28):4225-4235. PubMed ID: 29932645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of mitochondrial proteostasis by the proton gradient.
    Patron M; Tarasenko D; Nolte H; Kroczek L; Ghosh M; Ohba Y; Lasarzewski Y; Ahmadi ZA; Cabrera-Orefice A; Eyiama A; Kellermann T; Rugarli EI; Brandt U; Meinecke M; Langer T
    EMBO J; 2022 Aug; 41(16):e110476. PubMed ID: 35912435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.